Sustaining synergy & distinction in science
Enhancing clinical effectiveness
Our goal is to improve the performance of existing treatments for certain autoimmune diseases, cancers, and other near market opportunities with the potential to impact patients’ lives. We plan to achieve this by developing and commercializing new drug dosage forms, concentrations, and modes of delivery. These modifications can potentially improve the safety profile, bioavailability, tolerability, and efficacy of existing medications, leading to better patient compliance and improved patient outcomes.